Michael E. DeBakey VA Medical Center — Houston, Texas

Public research footprint of Michael E. DeBakey VA Medical Center, compiled from the ClinicalTrials.gov public registry.

320

Registered studies

Active

Recruiting now

197

Completed

Stopped or withdrawn

Most-studied conditions

Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma · Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 · Metastatic Urothelial Carcinoma

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT00588770 — Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or… (Active Not Recruiting)
NCT07164443 — A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Michael E. DeBakey VA Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.